PRISM DigitalMedia

BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study

Oct 24, 2023

Study to support differentiated efficacy of Vendaje® structural tissue allograft POMPANO BEACH, FLORIDA, October 24, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announced that the first site is now fully opened for its clinical trial, evaluating the Vendaje® tissue allograft in the treatment of diabetic foot ulcers (DFU). Jason...

Argentum 47, Inc. Moves into Online Cloud Business with New SaaS Module

Oct 24, 2023

WINDSOR, BERKSHIRE, UK, October 24, 2023 – Argentum 47, Inc. (OTC PINK: ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead generation, today announced that it has developed the Company’s proprietary AI Technology and platforms into a SaaS (Software-as-a-Service) model. Argentum 47 unifies all aspects of Marketing under one roof in order to enhance efficiency and coherence in marketing strategies. The ARG-AI module is designed to...

Metatron Partners with MML Marketing, Boasting a Proven Track Record of $19M in Sales

Oct 23, 2023

Dover, DE, October 23, 2023 - Metatron Apps Inc., (OTC: MRNJ) cements its position in the competitive world of AI and mobile app development, reflecting a perfect amalgamation of technological sophistication and strategic financial planning. In collaboration with MML Marketing, celebrated for generating over $19 million in internet sales, Metatron is poised for an unprecedented expansion in offering elite AI services. AI Made Easy Metatron is spearheading the "AI For ALL" initiative, a...

Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference

Oct 23, 2023

Pittsburgh, PA, October 23, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th - 27th. Dr. Jonathan Kaufman, CEO of Lipella, said: “2023 continues to be a year of significant milestone achievements for Lipella. Early in the year, we were delighted to report...

NEWSROOM

BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study

Argentum 47, Inc. Moves into Online Cloud Business with New SaaS Module

Metatron Partners with MML Marketing, Boasting a Proven Track Record of $19M in Sales

Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference

Contact Us